Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 33, 2022 - Issue 1
Submit an article Journal homepage
992
Views
18
CrossRef citations to date
0
Altmetric
Articles

Ustekinumab in the treatment of patients with hidradenitis suppurativa: multicenter case series and systematic review

T. Montero-Vilcheza Hidradenitis Suppurativa Clinic, Dermatology Unit, Hospital Universitario Virgen de las Nieves, Granada, Spain;b Instituto de Investigación Biosanitaria IBS, Granada, SpainORCID Iconhttps://orcid.org/0000-0003-4035-7955
ORCID Icon,
T. Pozo-Románc Servicio de Dermatología, Hospital Universitario Rio Ortega, Valladolid, Spain
,
L. Sánchez-Veliciac Servicio de Dermatología, Hospital Universitario Rio Ortega, Valladolid, Spain
,
J. Vega-Gutiérrezc Servicio de Dermatología, Hospital Universitario Rio Ortega, Valladolid, Spain
,
S. Arias-Santiagoa Hidradenitis Suppurativa Clinic, Dermatology Unit, Hospital Universitario Virgen de las Nieves, Granada, Spain;b Instituto de Investigación Biosanitaria IBS, Granada, SpainCorrespondence[email protected]
&
A. Molina-Leyvaa Hidradenitis Suppurativa Clinic, Dermatology Unit, Hospital Universitario Virgen de las Nieves, Granada, Spain;b Instituto de Investigación Biosanitaria IBS, Granada, Spain;d European Hidradenitis Suppurativa Foundation (EHSF), Dessau-Roßlau, Germany
Pages 348-353 | Received 09 Mar 2020, Accepted 05 Apr 2020, Published online: 21 Apr 2020

Citations (18)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Fabrizio Martora, Matteo Megna, Teresa Battista, Luca Potestio, Maria Carmela Annunziata, Claudio Marasca, Alessia Villani & Gabriella Fabbrocini. (2023) Adalimumab, Ustekinumab, and Secukinumab in the Management of Hidradenitis Suppurativa: A Review of the Real-Life Experience. Clinical, Cosmetic and Investigational Dermatology 16, pages 135-148.
Read now
Sophie Vieujean, Edouard Louis, Silvio Danese & Laurent Peyrin-Biroulet. (2023) A critical review of ustekinumab for the treatment of active ulcerative colitis in adults. Expert Review of Gastroenterology & Hepatology 17:5, pages 413-430.
Read now
Stella X. Chen, Charlotte Greif, Ruby S. Gibson, Martina L. Porter & Alexa B. Kimball. (2022) Advances in biologic and small molecule therapies for hidradenitis suppurativa. Expert Opinion on Pharmacotherapy 23:8, pages 959-978.
Read now

Articles from other publishers (15)

Marília Oliveira, Kassim Rahawi, Yinghui Duan, Michael Lane, Ahmad Z. Amin & Christopher J. Sayed. (2023) Effect of Biologics on the Need for Procedural Interventions, Systemic Medications, and Healthcare Utilization in Patients with Hidradenitis Suppurativa: Real-World Data from the UNITE Registry. Dermatology and Therapy 13:7, pages 1577-1585.
Crossref
Pablo Fernandez-Crehuet, Sofía Haselgruber, Alicia Padial-Gomez, Fiorella Vasquez-Chinchay, Maria Dolores Fernandez-Ballesteros, Irene López-Riquelme, David Jimenez-Gallo, Juan Manuel Segura-Palacios, Marisol Contreras-Steyls, Giovana Fernanda Osorio-Gómez, Juan Carlos Hernández-Rodríguez, Manuel Sanchez-Diaz, Carlos Cuenca-Barrales, Salvador Arias-Santiago & Alejandro Molina-Leyva. (2023) Short-Term Effectiveness, Safety, and Potential Predictors of Response of Secukinumab in Patients with Severe Hidradenitis Suppurativa Refractory to Biologic Therapy: A Multicenter Observational Retrospective Study. Dermatology and Therapy 13:4, pages 1029-1038.
Crossref
Rohan Mital, Ashley Gray, Abena Minta, Farah Almhana, Sabrina Amin, Jourdan Hydol-Smith, Teja Mallela & Benjamin H. Kaffenberger. (2022) Novel and Off-Label Biologic Use in the Management of Hidradenitis Suppurativa, Pyoderma Gangrenosum, Lichen Planus, and Seborrheic Dermatitis: A Narrative Review. Dermatology and Therapy 13:1, pages 77-94.
Crossref
O. Dereure. (2022) Quoi de neuf en thérapeutique dermatologique ?. Annales de Dermatologie et de Vénéréologie - FMC 2:8, pages 2/8S101-2/8S109.
Crossref
Federica Repetto, Lorenza Burzi, Simone Ribero, Pietro Quaglino & Paolo Dapavo. (2022) Efficacy and Safety of Risankizumab in Hidradenitis Suppurativa: A Case Series. Acta Dermato-Venereologica 102, pages adv00780.
Crossref
Terri Shih, Katrina Lee, Tristan Grogan, Devea R. De, Vivian Y. Shi & Jennifer L. Hsiao. (2022) Infliximab in hidradenitis suppurativa: A systematic review and meta‐analysis. Dermatologic Therapy 35:9.
Crossref
Sahil Rawal, Sara Kianian, William Guo, Jocellie Marquez, Marissa Ayasse, Katherine A. Siamas, Yoojin Lee & Joann Salvemini. (2021) Alternative uses of ustekinumab for non-indicated dermatological conditions: a systematic review. Archives of Dermatological Research 314:6, pages 503-514.
Crossref
Adela Markota Čagalj, Branka Marinović & Zrinka Bukvić Mokos. (2022) New and Emerging Targeted Therapies for Hidradenitis Suppurativa. International Journal of Molecular Sciences 23:7, pages 3753.
Crossref
Raffaele Dante Caposiena Caro, Chiara Pensa, Sara Lambiase, Eleonora Candi & Luca Bianchi. (2021) Risankizumab effectiveness in a recalcitrant case of hidradenitis suppurativa after anti‐TNF and anti‐ interleukin‐17 failures . Dermatologic Therapy 34:6.
Crossref
Elia Rosi, Maria Thais Fastame, Ilaria Scandagli, Antonella Di Cesare, Federica Ricceri, Nicola Pimpinelli & Francesca Prignano. (2021) Insights into the Pathogenesis of HS and Therapeutical Approaches. Biomedicines 9:9, pages 1168.
Crossref
E. Marques, P. Arenberger, A. Smetanová, S. Gkalpakiotis, D. Zimová & M. Arenbergerová. (2021) Successful treatment of recalcitrant hidradenitis suppurativa with risankizumab after failure of anti‐tumour necrosis factor alpha. British Journal of Dermatology 184:5, pages 966-967.
Crossref
Victoria Amat-Samaranch, Eugènia Agut-Busquet, Eva Vilarrasa & Lluís Puig. (2021) New perspectives on the treatment of hidradenitis suppurativa. Therapeutic Advances in Chronic Disease 12, pages 204062232110559.
Crossref
Ester Del Duca, Paola Morelli, Luigi Bennardo, Cosimo Di Raimondo & Steven Paul Nisticò. (2020) Cytokine Pathways and Investigational Target Therapies in Hidradenitis Suppurativa. International Journal of Molecular Sciences 21:22, pages 8436.
Crossref
Eva M. Sánchez‐Martínez, Ramón García‐Ruiz, Lya Magdalena Moneva‐Léniz & Almudena Mateu‐Puchades. (2020) Effectiveness and safety of ustekinumab in patients with hidradenitis suppurativa using intravenous induction. Dermatologic Therapy 33:6.
Crossref
Uwe Wollina, Piotr Brzezinski, André Koch & Wolfgang G. Philipp‐Dormston. (2020) Immunomodulatory drugs alone and adjuvant to surgery for hidradenitis suppurativa/acne inversa—A narrative review. Dermatologic Therapy 33:6.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.